Lynk Pharmaceuticals Co., Ltd. | 浙ICP备19010130号-2 | Powered by www.300.cn | Manager
CONTACT US
website
291 Fucheng Road, Bldg 5-402, Jianggan, Hangzhou,
Zhejiang 310018, China
PARTNER
CENTER OF DRUG DISCOVERY
OUT-LICENSING PARTNER
(To be disclosed later)
Founded on May 8, 2020
By the Institute of Cancer & Basic Medicine,
Chinese Academy of Sciences and Lynk
Pharmaceuticals
IN-LICENSING PARTNERS
Lynk successfully in-licensed RAS inhibitors
with novel mechanism of action (global rights)
from a Kobe university (Japan) & RIKEN research
institute (Japan) on July 16th, 2020